Orthotopic liver transplantation is the only available treatment for severe liver failure, but it is currently limited by organ shortage. One technical challenge that has thus far limited the development of a tissue-engineered liver graft is oxygen and nutrient transport. Here we demonstrate a novel approach to generate transplantable liver grafts using decellularized liver matrix. The decellularization process preserves the structural and functional characteristics of the native microvascular network, allowing efficient recellularization of the liver matrix with adult hepatocytes and subsequent perfusion for in vitro culture. The recellularized graft supports liver-specific function including albumin secretion, urea synthesis and cytochrome P450 expression at comparable levels to normal liver in vitro. The recellularized liver grafts can be transplanted into rats, supporting hepatocyte survival and function with minimal ischemic damage. These results provide a proof of principle for the generation of a transplantable liver graft as a potential treatment for liver disease.
At a glance
- Deaths: Final Data for 2006. in National Vital Statistics Report, Vol. 57 (Centers for Disease Control and Prevention, Hyattsville, Maryland, 2009). et al.
- Organ donation and utilization in the United States, 1996–2005. Am. J. Transplant. 7, 1327–1338 (2007). , , , &
- Hepatocyte transplantation. J. Hepatol. 40, 878–886 (2004). &
- Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63, 559–569 (1997). et al.
- Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111, 1262–1267 (2003). et al.
- Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338, 1422–1426 (1998). et al.
- Human hepatocyte transplantation: worldwide results. Transplantation 82, 441–449 (2006). &
- Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58, 951–952 (1994). , , &
- Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology 132, 321–329 (2007). et al.
- Differentiation and transplantation of human embryonic stem cell–derived hepatocytes. Gastroenterology 136, 990–999 (2009). et al.
- Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure. FASEB J. 22, 898–909 (2008). et al.
- Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated self-recombination. J. Hepatol. 47, 74–82 (2007). et al.
- Liver stem cells and prospects for liver reconstitution by transplanted cells. Hepatology 43, S89–S98 (2006). , , , &
- Cell transplantation in the treatment of liver diseases. Pediatr. Transplant. 12, 6–13 (2008). , &
- Tissue engineering. Science 260, 920–926 (1993). &
- Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue. Eng. Part A 14, 227–236 (2008). , , , &
- Integration of technologies for hepatic tissue engineering. Adv. Biochem. Eng. Biotechnol. 103, 309–329 (2007). , &
- Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets. Nat. Med. 13, 880–885 (2007). et al.
- Hepatic tissue engineering. Transpl. Immunol. 12, 303–310 (2004). &
- Endothelium-mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro . Tissue Eng. 12, 1627–1638 (2006). , , , &
- The extracellular matrix as a biologic scaffold material. Biomaterials 28, 3587–3593 (2007).
- Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 51, 221–225 (1998). , , &
- Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 12, 659–666 (2003). , , &
- Reinforcement of esophageal anastomoses with an extracellular matrix scaffold in a canine model. Ann. Thorac. Surg. 82, 2050–2058 (2006). , &
- Engraftment of a vascularized human skin equivalent. FASEB J. 17, 2250–2256 (2003). et al.
- Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023–2030 (2008). et al.
- Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14, 213–221 (2008). et al.
- Clinical death symposium. Crit. Care Med. 16, 919–920 (1988).
- Measurement of the synthesis of liver-produced plasma proteins with particular reference to dietary protein and amino acid supply. Biochem. J. 129, 3P (1972).
- Microscale culture of human liver cells for drug development. Nat. Biotechnol. 26, 120–126 (2008). &
- Recovery of warm ischemic rat liver grafts by normothermic extracorporeal perfusion. Transplantation 87, 170–177 (2009). et al.
- Diluted blood reperfusion as a model for transplantation of ischemic rat livers: alt is a direct indicator of viability. Transplant. Proc. (in the press). et al.
- Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures. Biotechnol. Bioeng. 97, 188–199 (2007). et al.
- Oxygen is a factor determining in vitro tissue assembly: effects on attachment and spreading of hepatocytes. Biotechnol. Bioeng. 43, 654–660 (1994). et al.
- Optimization of hepatocyte attachment to microcarriers: importance of oxygen. Biotechnol. Bioeng. 42, 579–588 (1993). et al.
- Oxygen consumption characteristics of porcine hepatocytes. Metab. Eng. 1, 49–62 (1999). et al.
- Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 7, 237–245 (1991). , &
- Improved technique of heterotopic auxiliary rat liver transplantation with portal vein arterialization. Langenbecks Arch. Surg. 391, 102–107 (2006). et al.
- Supplementary Text and Figures (4M)
Supplementary Tables 1 and 2, Supplementary Figures 1–5 and Supplementary Methods